1 min read
Add as a preferred source on GoogleGlobus Medical Q3 Revenue Misses Estimates as Non-GAAP EPS Beats
Revenue fell 0.7% year over year to $763.7 million, while base-business sales excluding Nevro rose 3%.
Globus Medical's third-quarter non-GAAP earnings per share beat estimates, while revenue missed forecasts, leaving the results split across the company's two headline measures at $1.23 per share and $763.7 million.
The non-GAAP per-share figure exceeded the estimate by 3 cents. Revenue was $28.76 million below estimates and down 0.7% from the same period a year earlier.
Separately, sales from Globus Medical's base business, excluding Nevro, totaled $690 million. That figure was up 3% on a reported basis.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.